Table of Contents
Hepatitis Research and Treatment
Volume 2013, Article ID 293274, 6 pages
http://dx.doi.org/10.1155/2013/293274
Research Article

Transforming Growth Factor-β1 Gene Polymorphism (T29C) in Egyptian Patients with Hepatitis B Virus Infection: A Preliminary Study

1Molecular Biology Department, Genetic Engineering and Biotechnology Research Institute (GEBRI), University of Sadat City, Sadat City 22857, Egypt
2Biochemistry Department, National Liver Institute (NLI), Menoufiya University, Shebeen El-Kom, Menoufiya 32511, Egypt
3Animal Biotechnology Department, Genetic Engineering and Biotechnology Research Institute (GEBRI), University of Sadat City, Sadat City 22857, Egypt

Received 7 May 2013; Revised 15 October 2013; Accepted 29 October 2013

Academic Editor: Piero Luigi Almasio

Copyright © 2013 Roba M. Talaat et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. J. Sonneveld, V. Rijckborst, C. A. B. Boucher, B. E. Hansen, and H. L. A. Janssen, “Prediction of sustained response to peginterferon alfa-2b for hepatitis B e antigen-positive chronic hepatitis B using on-treatment hepatitis B surface antigen decline,” Hepatology, vol. 52, no. 4, pp. 1251–1257, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. M. C. Kew, “Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma,” Pathologie Biologie, vol. 58, no. 4, pp. 273–277, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Fattovich, “Natural history and prognosis of hepatitis B,” Seminars in Liver Disease, vol. 23, no. 1, pp. 47–58, 2003. View at Google Scholar · View at Scopus
  4. R. Bataller, K. E. North, and D. A. Brenner, “Genetic polymorphisms and the progression of liver fibrosis: a critical appraisal,” Hepatology, vol. 37, no. 3, pp. 493–503, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Massague, “TGFbeta in cancer,” Cell, vol. 134, no. 2, pp. 215–230, 2008. View at Google Scholar
  6. W. A. Border and N. A. Noble, “Transforming growth factor β in tissue fibrosis,” The New England Journal of Medicine, vol. 331, no. 19, pp. 1286–1292, 1994. View at Publisher · View at Google Scholar · View at Scopus
  7. B. Li, A. Khanna, V. Sharma, T. Singh, M. Suthanthiran, and P. August, “TGF-β1 DNA polymorphisms, protein levels, and blood pressure,” Hypertension, vol. 33, no. 1, pp. 271–275, 1999. View at Google Scholar · View at Scopus
  8. P. Bedossa and V. Paradis, “Transforming growth factor-β (TGF-β): a key-role in liver fibrogenesis,” Journal of Hepatology, vol. 22, supplement 2, pp. 37–42, 1995. View at Google Scholar · View at Scopus
  9. A. M. Gressner, “Cytokines and cellular crosstalk involved in the activation of fat-storing cells,” Journal of Hepatology, vol. 22, supplement 2, pp. 28–36, 1995. View at Google Scholar · View at Scopus
  10. J. Gewaltig, K. Mangasser-Stephan, C. Gartung, S. Biesterfeld, and A. M. Gressner, “Association of polymorphisms of the transforming growth factor-β1 gene with the rate of progression of HCV-induced liver fibrosis,” Clinica Chimica Acta, vol. 316, no. 1-2, pp. 83–94, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. J. H. Kehrl, L. M. Wakefield, A. B. Roberts et al., “Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth,” Journal of Experimental Medicine, vol. 163, no. 5, pp. 1037–1050, 1986. View at Google Scholar · View at Scopus
  12. D. Fujii, J. E. Brissenden, R. Derynck, and U. Francke, “Transforming growth factor β gene maps to human chromosome 19 long arm and to mouse chromosome 7,” Somatic Cell and Molecular Genetics, vol. 12, no. 3, pp. 281–288, 1986. View at Google Scholar · View at Scopus
  13. R. Derynck, L. Rhee, E. Y. Chen, and A. van Tilburg, “Intron-exon structure of the human transforming growth factor-β precursor gene,” Nucleic Acids Research, vol. 15, no. 7, pp. 3188–3189, 1987. View at Google Scholar · View at Scopus
  14. Y. Watanabe, A. Kinoshita, T. Yamada et al., “A catalog of 106 single-nucleotide polymorphisms (SNPs) and 11 other types of variations in genes for transforming growth factor-β1 (TGF-β1) and its signaling pathway,” Journal of Human Genetics, vol. 47, no. 9, pp. 478–483, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Yamada, A. Miyauchi, J. Goto et al., “Association of a polymorphism of the transforming growth factor-β1 gene with genetic susceptibility to osteoporosis in postmenopausal Japanese women,” Journal of Bone and Mineral Research, vol. 13, no. 10, pp. 1569–1576, 1998. View at Publisher · View at Google Scholar · View at Scopus
  16. D. J. Grainger, K. Heathcote, M. Chiano et al., “Genetic control of the circulating concentration of transforming growth factor type β1,” Human Molecular Genetics, vol. 8, no. 1, pp. 93–97, 1999. View at Publisher · View at Google Scholar · View at Scopus
  17. L. L. Randall and S. J. S. Hardy, “Unity in function in the absence of consensus in sequence: role of leader peptides in export,” Science, vol. 243, no. 4895, pp. 1156–1159, 1989. View at Google Scholar · View at Scopus
  18. F. Cambien, S. Ricard, A. Troesch et al., “Polymorphisms of the transforming growth factor-β1 gene in relation to myocardial infarction and blood pressure: the Etude Cas-Temoin de l'Infarctus du Myocarde (ECTIM) study,” Hypertension, vol. 28, no. 5, pp. 881–887, 1996. View at Google Scholar · View at Scopus
  19. M. Suthanthiran, B. Li, J. O. Song et al., “Transforming growth factor-β1 hyperexpression in African-American hypertensives: a novel mediator of hypertension and/or target organ damage,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 7, pp. 3479–3484, 2000. View at Google Scholar · View at Scopus
  20. A. M. Dunning, P. D. Ellis, S. McBride et al., “A transforming growth factorβ1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer,” Cancer Research, vol. 63, no. 10, pp. 2610–2615, 2003. View at Google Scholar · View at Scopus
  21. J. Kirshner, M. F. Jobling, M. J. Pajares et al., “Inhibition of transforming growth factor-β1 signaling attenuates ataxia telangiectasia mutated activity in response to genotoxic stress,” Cancer Research, vol. 66, no. 22, pp. 10861–10869, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Yokota, S. Ichihara, T.-L. Lin, N. Nakashima, and Y. Yamada, “Association of a T29→C polymorphism of the transforming growth factor- β1 gene with genetic susceptibility to myocardial infarction in japanese,” Circulation, vol. 101, no. 24, pp. 2783–2787, 2000. View at Google Scholar · View at Scopus
  23. L. Le Marchand, C. A. Haiman, D. van den Berg, L. R. Wilkens, L. N. Kolonel, and B. E. Henderson, “T29C polymorphism in the transforming growth factor β1 gene and postmenopausal breast cancer risk: the multiethnic cohort study,” Cancer Epidemiology Biomarkers and Prevention, vol. 13, no. 3, pp. 412–415, 2004. View at Google Scholar · View at Scopus
  24. K. Welsh and M. Bunce, “Molecular typing for the MHC with PCR-SSP,” Reviews in Immunogenetics, vol. 1, no. 2, pp. 157–176, 1999. View at Google Scholar · View at Scopus
  25. E. E. Powell, C. J. Edwards-Smith, J. L. Hay et al., “Host genetic factors influence disease progression in chronic hepatitis C,” Hepatology, vol. 31, no. 4, pp. 828–833, 2000. View at Google Scholar · View at Scopus
  26. P. D. Griffiths, “Interactions between viral and human genes,” Reviews in Medical Virology, vol. 12, no. 4, pp. 197–199, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Dean, M. Carrington, and S. J. O'Brien, “Balanced polymorphism selected by genetic versus infectious human disease,” Annual Review of Genomics and Human Genetics, vol. 3, pp. 263–292, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Bidwell, L. Keen, G. Gallagher et al., “Cytokine gene polymorphism in human disease: on-line databases,” Genes and Immunity, vol. 1, no. 1, pp. 3–19, 1999. View at Google Scholar · View at Scopus
  29. M. Thursz, “Genetic susceptibility in chronic viral hepatitis,” Antiviral Research, vol. 52, no. 2, pp. 113–116, 2001. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Almarri and J. R. Batchelor, “HLA and hepatitis B infection,” The Lancet, vol. 344, no. 8931, pp. 1194–1195, 1994. View at Publisher · View at Google Scholar · View at Scopus
  31. Z. Ben-Ari, E. Mor, O. Papo et al., “Cytokine gene polymorphisms in patients infected with hepatitis B virus,” American Journal of Gastroenterology, vol. 98, no. 1, pp. 144–150, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. R. G. J. Westendorp, J. A. M. Langermans, T. W. J. Huizinga et al., “Genetic influence on cytokine production and fatal meningococcal disease,” The Lancet, vol. 349, no. 9046, pp. 170–173, 1997. View at Publisher · View at Google Scholar · View at Scopus
  33. J. L. Bidwell, N. A. P. Wood, H. R. Morse, O. O. Olomolaiye, L. J. Keen, and G. J. Laundy, “Human cytokine gene nucleotide sequence alignments,” European Journal of Immunogenetics, vol. 26, no. 2-3, pp. 135–223, 1999. View at Publisher · View at Google Scholar · View at Scopus
  34. S. J. H. van Deventer, “Cytokine and cytokine receptor polymorphisms in infectious disease,” Intensive Care Medicine, vol. 26, supplement 1, pp. S98–S102, 2000. View at Google Scholar · View at Scopus
  35. J. C. Celedón, C. Lange, B. A. Raby et al., “The transforming growth factor-β1 (TGFB1) gene is associated with Chronic Obstructive Pulmonary Disease (COPD),” Human Molecular Genetics, vol. 13, no. 15, pp. 1649–1656, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. E. S. Silverman, L. J. Palmer, V. Subramaniam et al., “Transforming growth factor-β1 promoter polymorphism C-509T is associated with asthma,” American Journal of Respiratory and Critical Care Medicine, vol. 169, no. 2, pp. 214–219, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. L. Wu, J. Chau, R. P. Young et al., “Transforming growth factor-β1 genotype and susceptibility to chronic obstructive pulmonary disease,” Thorax, vol. 59, no. 2, pp. 126–129, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. Y. Yamada, “Association of polymorphisms of the transforming growth factor-β1 gene with genetic susceptibility to osteoporosis,” Pharmacogenetics, vol. 11, no. 9, pp. 765–771, 2001. View at Publisher · View at Google Scholar · View at Scopus
  39. A. M. González-Zuloeta Ladd, A. Arias-Vásquez, C. Siemes et al., “Transforming-growth factor β1 Leu10Pro polymorphism and breast cancer morbidity,” European Journal of Cancer, vol. 43, no. 2, pp. 371–374, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. P. D. Arkwright, S. Laurie, M. Super et al., “TGF-β1 genotype and accelerated decline in lung function of patients with cystic fibrosis,” Thorax, vol. 55, no. 6, pp. 459–462, 2000. View at Publisher · View at Google Scholar · View at Scopus
  41. V. Hinke, T. Seck, C. Clanget, C. Scheidt-Nave, R. Ziegler, and J. Pfeilschifter, “Association of transforming growth factor-β1 (TGFβ1) T29→C gene polymorphism with bone mineral density (BMD), changes in BMD, and serum concentrations of TGF-β1 in a population-based sample of postmenopausal German women,” Calcified Tissue International, vol. 69, no. 6, pp. 315–320, 2001. View at Publisher · View at Google Scholar · View at Scopus
  42. X. Li, Z.-C. Yue, Y.-Y. Zhang et al., “Elevated serum level and gene polymorphisms of TGF-β1 in gastric cancer,” Journal of Clinical Laboratory Analysis, vol. 22, no. 3, pp. 164–171, 2008. View at Publisher · View at Google Scholar · View at Scopus